RMDA.EGX Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda

5.20 EGP
Close of Oct 29, 2026
3.09 6.94
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is RMDA.EGX undervalued?

Graham number

The Graham number of Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda fundamental analysis

No fundamental analysis for Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda yet.

Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.